argenx announced that during the extraordinary general meeting of shareholders Mrs. Camilla Sylvest was appointed as non-executive director to its Board of Directors. Mrs. Sylvest brings strong strategic and operational leadership in the scaling of global commercial pharmaceutical organizations with a specific focus on company culture and sustainability.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
337.7 EUR | -1.40% | +0.93% | -1.69% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.69% | 22.1B | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B | |
-30.73% | 7.55B |
- Stock Market
- Equities
- ARGX Stock
- News argenx SE
- Argenx Appoints Camilla Sylvest to Board of Directors